Researchers at the Indian Institute of Technology (IIT) in Madras have created a groundbreaking microfluidic device that can quickly determine the susceptibility of bacteria to antibiotics. This device stands out from contemporary methods by utilizing screen-printed carbon electrodes in a straightforward microfluidic chip, eliminating the need for expensive metals or intricate fabrication processes.
The lab-on-chip device provides results within three hours, employing Electrochemical Impedance Spectroscopy. This innovation not only accelerates the diagnosis process but also enhances the accuracy of treatment decisions. The affordability and simplicity of this device enable its potential deployment in smaller healthcare facilities and rural areas that lack access to advanced laboratory equipment.
Antimicrobial resistance (AMR) poses a significant threat to global healthcare systems, with nearly 4.95 million deaths worldwide in 2019 attributed to bacterial AMR. The IIT Madras device, known as ε-µD, offers a cost-effective solution for phenotypic testing, utilizing electrochemical signals to evaluate bacterial growth and susceptibility to antibiotics. By addressing key criteria outlined by the World Health Organization (WHO), including affordability and speed, ε-µD aims to make antimicrobial susceptibility testing more accessible, particularly in low-resource settings.
Published in the prestigious Nature Scientific Reports, the research highlights the device’s innovative use of a nutrient solution that not only supports bacterial growth for testing but also enhances the sensitivity of electrical signals used for detection. The device’s ability to detect responses to different antibiotics, such as ampicillin and tetracycline, showcases its versatility and reliability in assessing bacterial susceptibility.
Clinical validation of the device is currently underway in collaboration with the IITM Institute Hospital, with plans for commercialization through the startup Kaappon Analytics India Private Limited. This advancement in rapid antibiotic susceptibility testing has the potential to revolutionize treatment decisions, particularly for patients in intensive care units suffering from bacterial infections, where timely and accurate diagnosis is crucial for effective interventions.
In conclusion, the lab-on-chip device developed by IIT Madras represents a significant milestone in combating antimicrobial resistance and improving patient outcomes through rapid and accurate antibiotic susceptibility testing. By addressing the limitations of traditional testing methods and offering a cost-effective, user-friendly solution, this innovation has the potential to enhance healthcare delivery in resource-constrained settings and contribute to global efforts in combating AMR.
- The lab-on-chip device developed by IIT Madras offers a rapid and cost-effective solution for antibiotic susceptibility testing, addressing key challenges in global healthcare systems.
- Published in Nature Scientific Reports, the device’s innovative use of electrochemical signals and a specially prepared nutrient solution enhances sensitivity and accuracy in detecting bacterial responses to antibiotics.
- Clinical validation in collaboration with IITM Institute Hospital and plans for commercialization through Kaappon Analytics India Private Limited signify the device’s progression towards real-world implementation in healthcare settings.
- The device’s impact on patient care, particularly in intensive care units where timely and accurate diagnosis is critical, highlights its potential to revolutionize treatment decisions and improve outcomes in bacterial infections.
Tags: lab-on-chip
Read more on thehindubusinessline.com